Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 4
2010 9
2011 17
2012 22
2013 12
2014 20
2015 37
2016 28
2017 64
2018 28
2019 32
2020 27
2021 58
2022 41
2023 79
2024 76
2025 104
2026 96

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

747 results

Results by year

Filters applied: . Clear all
Page 1
Development and Validation of a Machine-Learning Deep Plasma Proteome Classifier for Early-Stage Breast Cancer Detection.
Horrmann A, Travadi Y, Carey J, Boytim E, Mallery K, Schaap G, Rungkittikhun C, Kamalanathan KJ, Bristow NR, Galeano-Garces C, Groth A, Ball H, Hesch AR, Advani P, Hwang J, Konety BR, Drake JM. Horrmann A, et al. Breast Cancer (Dove Med Press). 2026 Jul 30;18:609238. doi: 10.2147/BCTT.S609238. eCollection 2026. Breast Cancer (Dove Med Press). 2026. PMID: 42549258 Free PMC article.
Management of HER2+ Breast Cancer with and without Brain Metastases in Saudi Arabia: Literature Insights and an Expert Survey of Current Practices.
Kullab S, Refae A, Altwairgi A, Abusanad A, Elsamany S, Abdelhafiez NA, Basulaiman B, Zahralliyali A, Alshangiti AA, Al-Mubarak M, Alwbari A, Alharbi A, Osman A, Kiwan H, Alaklabi S. Kullab S, et al. Breast Cancer (Dove Med Press). 2026 May 27;18:599184. doi: 10.2147/BCTT.S599184. eCollection 2026. Breast Cancer (Dove Med Press). 2026. PMID: 42226887 Free PMC article.
From Axillary Lymph Node Dissection to Sentinel Node Biopsy in Breast Cancer: A 23-Year Population-Based Large-Sample Study with Long-Term Survival Outcomes.
Mangone L, Marinelli F, Bisceglia I, Braghiroli MB, Neri A, Morabito F, Pinto C, Ragazzi M, Ferrari G, Coiro S, Cenini E. Mangone L, et al. Breast Cancer (Dove Med Press). 2026 Apr 17;18:573154. doi: 10.2147/BCTT.S573154. eCollection 2026. Breast Cancer (Dove Med Press). 2026. PMID: 42022883 Free PMC article.
Capecitabine versus Paclitaxel After CDK4/6 Inhibitor Progression in Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: A Real-World Study.
Birsin Z, Güren AK, Aliyev V, Guliyev M, Jeral S, Cebeci S, Çerme E, Günaltılı M, Abbasov H, Çiçek E, Atak S, Sarı M, Demirci NS, Alan Ö. Birsin Z, et al. Breast Cancer (Dove Med Press). 2026 Apr 15;18:598598. doi: 10.2147/BCTT.S598598. eCollection 2026. Breast Cancer (Dove Med Press). 2026. PMID: 42011243 Free PMC article.
Bridging Clinical Trials to Real-World Clinical Practice: TCHP Neoadjuvant Therapy Outcomes in HER2-Positive Breast Cancer.
Sharaf B, Seif A, Bani Hani H, Alhasan M, Khader R, Al-Yag'oub M, Ghanem A, Bani Ata J, Ajlouni B, Jawarneh Q, Jaffal A, Tamimi F, Jehad S, Al-Abdallat H, Mahafdah O, Abdel-Razeq H. Sharaf B, et al. Breast Cancer (Dove Med Press). 2026 Apr 9;18:559555. doi: 10.2147/BCTT.S559555. eCollection 2026. Breast Cancer (Dove Med Press). 2026. PMID: 41982224 Free PMC article.
The Role of Actin-Binding Proteins in Breast Cancer Progression.
Alfarafisa NM, Herriyanto RI, Alhaq KF, Fauzi MB, Khairani AF. Alfarafisa NM, et al. Breast Cancer (Dove Med Press). 2026 Feb 19;18:566309. doi: 10.2147/BCTT.S566309. eCollection 2026. Breast Cancer (Dove Med Press). 2026. PMID: 41743193 Free PMC article. Review.
Endocrine Therapy versus Chemotherapy After CDK4/6 Inhibitor Progression in HR+/HER2- Metastatic Breast Cancer: A Multicenter Real-World Study from Turkey.
Cangür C, Bülbül B, Yeğen IT, Ucun B, Eren OÖ, Başaran H, Erdoğan AP, Şahin Hafızoğlu E, Gökmen E, Özkan O, Araz M, Oruç A, Yilmaz C, Gül G, Yildirim S. Cangür C, et al. Breast Cancer (Dove Med Press). 2026 Jan 14;18:571246. doi: 10.2147/BCTT.S571246. eCollection 2026. Breast Cancer (Dove Med Press). 2026. PMID: 41868693 Free PMC article.
Assessing Thrombotic Risk in Patients with HR+/HER2- Breast Cancer Receiving CDK4/6 Inhibitors: Insights from Real-World Data from the Middle East.
Alsuhebany N, Alanazi A, Alzahrani MY, Alyousef S, Aldawish BS, Aljardan S, Abu Alnasr R, Althumali IM, AlDoughaim M, Alfehaid L, Refae S, Abdelhafiez Jnr NA, Bakhribah H, Alqahtani T. Alsuhebany N, et al. Breast Cancer (Dove Med Press). 2026 Jan 10;18:554024. doi: 10.2147/BCTT.S554024. eCollection 2026. Breast Cancer (Dove Med Press). 2026. PMID: 41858528 Free PMC article.
Noncoding RNAs, Vital Players in Breast Cancer Metastasis.
Kang Y, Wang X, Liu Y, Cao J, Lin J, Qiao G. Kang Y, et al. Breast Cancer (Dove Med Press). 2025 Dec 30;17:1463-1492. doi: 10.2147/BCTT.S556045. eCollection 2025. Breast Cancer (Dove Med Press). 2025. PMID: 41488683 Free PMC article. Review.
Management Strategies and Outcomes in HR+/HER2- Metastatic Breast Cancer Receiving CDK4/6 Inhibitors and Subsequent Therapies.
Pogoda K, Pawlik H, Balata A, Czopowicz M, Bak A, Twardowska I, Meluch M, Wojda M, Mlodzinska A, Szombara E, Sienkiewicz R, Konieczna A, Brewczynska E, Lemanska I, Majstrak-Hulewska A, Gorniak A, Niwinska A, Nowecki Z. Pogoda K, et al. Breast Cancer (Dove Med Press). 2025 Dec 24;17:1307-1319. doi: 10.2147/BCTT.S567687. eCollection 2025. Breast Cancer (Dove Med Press). 2025. PMID: 41466771 Free PMC article.
Triple-Negative Breast Cancer on the Rise or…? [Letter].
Lønning PE, Nikolaienko O, Knappskog S. Lønning PE, et al. Breast Cancer (Dove Med Press). 2025 Sep 25;17:875-876. doi: 10.2147/BCTT.S560499. eCollection 2025. Breast Cancer (Dove Med Press). 2025. PMID: 41030522 Free PMC article. No abstract available.
Unveiling the Landscape of PD-L1 Expression and Tumor-Infiltrating Lymphocyte Subtypes in Advanced Triple-Negative Breast Cancer in Brazil.
Dos Santos ALS, Da Silva JL, De Albuquerque LZ, Neto ALA, Da Silva CF, Cerva LAM, Small IA, Rodrigues FR, De Macedo FC, Marcelino CP, Batista PM, Rego MADC, Borba MACSM, De Melo AC. Dos Santos ALS, et al. Breast Cancer (Dove Med Press). 2025 Apr 15;17:349-358. doi: 10.2147/BCTT.S499373. eCollection 2025. Breast Cancer (Dove Med Press). 2025. PMID: 40256247 Free PMC article.
Quality of Life in Breast Cancer Patients in Saudi Arabia: A Systematic Review.
Aljadani FF, Nughays RO, Alharbi GE, Almazroy EA, Elyas SK, Danish HE, Alanazi RT, Aldrees BA, Jadkarim GA, Mikwar Z. Aljadani FF, et al. Breast Cancer (Dove Med Press). 2025 Feb 18;17:171-186. doi: 10.2147/BCTT.S505725. eCollection 2025. Breast Cancer (Dove Med Press). 2025. PMID: 39990965 Free PMC article. Review.
Programmed Cell Death Ligand 1 (PD-L1) and Major Histocompatibility Complex Class I (MHC Class I) Expression Patterns and Their Pathologic Associations in Triple-Negative Breast Cancer.
Kaewkedsri P, Intarawichian P, Jessadapattarakul S, Kunprom W, Koonmee S, Thanee M, Somintara O, Wongbuddha A, Chadbunchachai P, Nawapun S, Aphivatanasiri C. Kaewkedsri P, et al. Breast Cancer (Dove Med Press). 2025 Feb 6;17:123-143. doi: 10.2147/BCTT.S506833. eCollection 2025. Breast Cancer (Dove Med Press). 2025. PMID: 39936074 Free PMC article.
Update on Pulmonary Toxicity Induced by New Breast Cancer Treatments.
Belluzzi L, Martinelli G, Medici B, Farina A, Martinelli E, Canino F, Caggia F, Molinaro A, Barbolini M, Tamburrano F, Moscetti L, Piacentini F, Dominici M, Omarini C. Belluzzi L, et al. Breast Cancer (Dove Med Press). 2025 Jan 21;17:53-66. doi: 10.2147/BCTT.S489419. eCollection 2025. Breast Cancer (Dove Med Press). 2025. PMID: 39867812 Free PMC article. Review.
747 results